Skip to main content

Animations

MJFF Publications

3391 - 3400 of 9145 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01282-8
    Citation Count: 259
  • Summary Details
    OPEN
    Title: Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and Dyskinesia
    Journal Name: Neurology and Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1007/s40120-021-00256-1
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Humanized Biomimetic Nanovesicles for Neuron Targeting
    Journal Name: Advanced Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/advs.202101437
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0257372
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-26066-5
    Citation Count: 224
  • Summary Details
    OPEN
    Title: Predicting PY motif-mediated protein-protein interactions in the Nedd4 family of ubiquitin ligases
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0258315
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Multivariate prediction of dementia in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-020-00121-2
    Citation Count: 59
  • Summary Details
    OPEN
    Title: Genetic variants and functional pathways associated with resilience to Alzheimer’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awaa209
    Citation Count: 141
  • Summary Details
    OPEN
    Title: Structural connectivity predicts clinical outcomes of deep brain stimulation for Tourette syndrome
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa188
    Citation Count: 79
  • Summary Details
    OPEN
    Title: Dopamine is associated with prioritization of reward-associated memories in Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awaa182
    Citation Count: 21
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.